A small trial in adults showed oral immunotherapy for peanut allergy allowed two-third of participants to tolerate up to 5 ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

A nondairy coffee creamer sold across the Northeast has been recalled after it was found that it could pose serious health ...